DNA sequencing of bacteria leads to discovery of mutation that helps VRE tolerate antibiotics
Mystery sensor protein NLRC3 revealed as a central player in preventing colon cells from becoming cancerous
Research reveals principal tumor suppressor function of ARID1A and suggests that loss of the protein contributes to colon cancer
A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
To improve patient safety, hospital leaders should provide feedback that demonstrates to staff the value of reporting safety events and errors.
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
New findings help increase understanding of molecular mechanisms for common forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Incorporating topotecan into front-line therapy of advanced localized retinoblastoma cures patients and improves survival of eyes with useful vision.
Researchers identify the molecular events that activate inflammasomes to initiate the innate immune response against bacterial invaders.
Explore more research news
More Research News
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators in 2015.